A novel triaptosis-related prognostic signature to assess the clinical value in HER2-low breast cancer: evidence from clinical cohorts and experimental validation
{{output}}
Background: HER2-low breast cancer (BC) represents a biologically distinct subtype with limited predictive biomarkers. Triaptosis is a recently described form of oxidative stress-associated endosomal dysfunction mediated by VPS34... ...
